In an effort to address these limitations for disseminated stomach cancer, we developed a pre-clinical mouse model to evaluate the role of a likely biomarker, DUOX2, on the effectiveness of chemopotentiation by LD-WART. Here, DUOX2 is linked to gastric cancer.